Treatment‘s side effects in MDR tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 454s Year: 2005
A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013
Comparative analysis between multidrug resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis (XDR-TB) in HIV(+) patients Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009
Prevalence of MDR and XDR tuberculosis among patients with failure of re-treatment course Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008
Frequency of development acquired drug resistance in successful treated patients with newly detected pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 612s Year: 2002
Markers of thyroid dysfunction in patients with MDR tuberculosis. Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Multidrug resistant tuberculosis in non HIV patients Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007
Comorbidome in multidrug-resistant tuberculosis patients Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020
Treatment of multidrug resistant pulmonary tuberculosis (MDR-TB) with different pattern of resistance Source: Eur Respir J 2004; 24: Suppl. 48, 723s Year: 2004
Treatment effectiveness among newly detected patients with polyresistant tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 651s Year: 2005
Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008
Follow-up and treatment of patients who were diagnosed multidrug resistant tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 11s Year: 2006
Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004
Diagnosis of COPD in patients with multidrug-resistant tuberculosis Source: International Congress 2018 – COPD around the world Year: 2018
Artificial pneumothorax in the treatment of multi drug resistant tuberculosis (MDR TB) Source: Eur Respir J 2006; 28: Suppl. 50, 586s Year: 2006
Our experience in multi drug resistant tuberculosis (MDR TB) treatment Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005
Treatment results of multidrug resistant pulmonary tuberculosis (MDR-TB) Source: Eur Respir J 2005; 26: Suppl. 49, 199s Year: 2005
Characteristics of the cases with primary multidrug resistance pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 652s Year: 2005
Recurrence after successful treatment of pulmonary tuberculosis (TB) with multidrug-resistance (MDR) Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008
The prevalence of drug resistance tuberculosis in previously treated patients Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008